Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Stock Gains As Company Gets Orphan Drug Designation
The biopharmaceutical sector has almost always managed to draw the attention of investors over the course of the past few years and it is expected to be the case in the near future as well. Many of the companies in the sector have been doing highly innovative work in recent years and that is something that could be highly attractive to investors of many stripes. If you are looking into…